Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Schema
  9. External Links
  10. Analytics And Tracking
  11. Libraries
  12. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s00401-013-1100-2.

Title:
Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells | Acta Neuropathologica
Description:
Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF V600E mutation was identified in approximately 20 % of gangliogliomas. Here, we analyzed a total of 71 gangliogliomas for BRAF V600E mutational status by VE1 immunohistochemistry and direct DNA sequencing. The BRAF V600E mutation was detected in 41/71 (58 %) gangliogliomas by immunohistochemistry. DNA sequencing was concordant in 60 of 62 analyzed cases. BRAF status was compared with clinical, histological and immunohistochemical data. Presence of the BRAF V600E mutation was associated with expression of synaptophysin in the tumor (p = 0.0008), presence of dysplastic neurons (p = 0.011) and lymphocytic cuffs (p = 0.018), and with younger age (p = 0.0054). Extensive hemosiderin deposition within the tumor was significantly associated with BRAF wild-type status (p = 0.042). No significant association was found with proliferation (p = 0.053), presence of phospho ERK (p = 0.1) or senescence marker p16INK4a (p = 0.22). Using VE1, we localized the BRAF V600E-mutated protein predominantly to the neuronal compartment, indicating that BRAF mutations occur in cells that have the capacity to differentiate into ganglionic cells. In many cases mutant BRAF is additionally expressed by the glial compartment, indicating that in these cases the cell targeted by BRAF mutation was likely capable of differentiating along both the ganglionic and glial lineages. No cases with an exclusive expression of BRAF V600E in the glial compartment were observed. Thus, using VE1 we identified the neuronal compartment as an essential part of this mixed glioneuronal tumor.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Education
  • Science
  • Health & Fitness

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 8,170,236 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💾}

We're unsure if the website is profiting.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com could be secretly minting cash, but we can't detect the process.

Keywords {🔍}

article, pubmed, google, scholar, braf, cas, cancer, deimling, mutation, capper, tumor, mutations, neuropathol, acta, cells, clinical, brain, pathol, ganglioglioma, preusser, gangliogliomas, res, pilocytic, pathway, status, glial, astrocytomas, university, analysis, mutant, protein, immunohistochemistry, access, gene, detection, clin, melanoma, germany, vienna, privacy, cookies, content, research, neuronal, immunohistochemical, doican, dois, reifenberger, neuropathology, heidelberg,

Topics {✒}

month download article/chapter central nervous system braf v600e-mutated protein rare cns tumor braf-kiaa1549 fusion transcripts mutation-specific monoclonal antibody ruprecht-karls-universitÀt heidelberg braf wild-type status adelheid wöhrer mapk pathway activation pediatric low-grade gliomas full article pdf monoclonal antibody ve1 andreas von deimling brafv600e mutant protein extra-cerebellar pilocytic astrocytoma braf v600e mutation v600e braf mutation map kinase signalling glial cells erk/mapk pathway braf v600e status braf insertion mutant clinical tumor samples oncogenic braf mutation neuronal tumor cells privacy choices/manage cookies braf v600e mutations cases mutant braf mixed glioneuronal tumor tumor suppressor proteins wild-type braf glial compartment glial lineages optic pathway tumours braf gene author information authors colorectal cancer independently low-grade glioma low-grade astrocytomas senescence marker p16ink4a brain tumor article koelsche check access serous ovarian tumors instant access braf mutations occur microsatellite instability status human breast cancer allele-specific pcr

Schema {đŸ—ș}

WebPage:
      mainEntity:
         headline:Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
         description:Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF V600E mutation was identified in approximately 20 % of gangliogliomas. Here, we analyzed a total of 71 gangliogliomas for BRAF V600E mutational status by VE1 immunohistochemistry and direct DNA sequencing. The BRAF V600E mutation was detected in 41/71 (58 %) gangliogliomas by immunohistochemistry. DNA sequencing was concordant in 60 of 62 analyzed cases. BRAF status was compared with clinical, histological and immunohistochemical data. Presence of the BRAF V600E mutation was associated with expression of synaptophysin in the tumor (p = 0.0008), presence of dysplastic neurons (p = 0.011) and lymphocytic cuffs (p = 0.018), and with younger age (p = 0.0054). Extensive hemosiderin deposition within the tumor was significantly associated with BRAF wild-type status (p = 0.042). No significant association was found with proliferation (p = 0.053), presence of phospho ERK (p = 0.1) or senescence marker p16INK4a (p = 0.22). Using VE1, we localized the BRAF V600E-mutated protein predominantly to the neuronal compartment, indicating that BRAF mutations occur in cells that have the capacity to differentiate into ganglionic cells. In many cases mutant BRAF is additionally expressed by the glial compartment, indicating that in these cases the cell targeted by BRAF mutation was likely capable of differentiating along both the ganglionic and glial lineages. No cases with an exclusive expression of BRAF V600E in the glial compartment were observed. Thus, using VE1 we identified the neuronal compartment as an essential part of this mixed glioneuronal tumor.
         datePublished:2013-02-24T00:00:00Z
         dateModified:2013-02-24T00:00:00Z
         pageStart:891
         pageEnd:900
         sameAs:https://doi.org/10.1007/s00401-013-1100-2
         keywords:
            BRAF V600E
            BRAF
            VE1
            Ganglioglioma
            Brain
            Tumor
            Pathology
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig1_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig2_HTML.jpg
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig3_HTML.gif
         isPartOf:
            name:Acta Neuropathologica
            issn:
               1432-0533
               0001-6322
            volumeNumber:125
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer-Verlag
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Christian Koelsche
               affiliation:
                     name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                     address:
                        name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Adelheid Wöhrer
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Astrid Jeibmann
               affiliation:
                     name:University Hospital MĂŒnster
                     address:
                        name:Institute of Neuropathology, University Hospital MĂŒnster, MĂŒnster, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Jens Schittenhelm
               affiliation:
                     name:University of TĂŒbingen
                     address:
                        name:Department of Neuropathology Institute of Pathology and Neuropathology, University of TĂŒbingen, TĂŒbingen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Genevieve Schindler
               affiliation:
                     name:Medical Faculty of the Ruhr University Bochum
                     address:
                        name:Department of Neurosurgery, Medical Faculty of the Ruhr University Bochum, Bochum, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Matthias Preusser
               affiliation:
                     name:Medical University of Vienna
                     address:
                        name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
                     name:Medical University of Vienna
                     address:
                        name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Felix Lasitschka
               affiliation:
                     name:University of Heidelberg
                     address:
                        name:Institute of Pathology, University of Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Andreas von Deimling
               affiliation:
                     name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                     address:
                        name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
               name:David Capper
               affiliation:
                     name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                     address:
                        name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
                     name:German Cancer Research Center (DKFZ)
                     address:
                        name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells
      description:Ganglioglioma is a rare CNS tumor with a benign biological behavior. Recently, the BRAF V600E mutation was identified in approximately 20 % of gangliogliomas. Here, we analyzed a total of 71 gangliogliomas for BRAF V600E mutational status by VE1 immunohistochemistry and direct DNA sequencing. The BRAF V600E mutation was detected in 41/71 (58 %) gangliogliomas by immunohistochemistry. DNA sequencing was concordant in 60 of 62 analyzed cases. BRAF status was compared with clinical, histological and immunohistochemical data. Presence of the BRAF V600E mutation was associated with expression of synaptophysin in the tumor (p = 0.0008), presence of dysplastic neurons (p = 0.011) and lymphocytic cuffs (p = 0.018), and with younger age (p = 0.0054). Extensive hemosiderin deposition within the tumor was significantly associated with BRAF wild-type status (p = 0.042). No significant association was found with proliferation (p = 0.053), presence of phospho ERK (p = 0.1) or senescence marker p16INK4a (p = 0.22). Using VE1, we localized the BRAF V600E-mutated protein predominantly to the neuronal compartment, indicating that BRAF mutations occur in cells that have the capacity to differentiate into ganglionic cells. In many cases mutant BRAF is additionally expressed by the glial compartment, indicating that in these cases the cell targeted by BRAF mutation was likely capable of differentiating along both the ganglionic and glial lineages. No cases with an exclusive expression of BRAF V600E in the glial compartment were observed. Thus, using VE1 we identified the neuronal compartment as an essential part of this mixed glioneuronal tumor.
      datePublished:2013-02-24T00:00:00Z
      dateModified:2013-02-24T00:00:00Z
      pageStart:891
      pageEnd:900
      sameAs:https://doi.org/10.1007/s00401-013-1100-2
      keywords:
         BRAF V600E
         BRAF
         VE1
         Ganglioglioma
         Brain
         Tumor
         Pathology
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig1_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig2_HTML.jpg
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00401-013-1100-2/MediaObjects/401_2013_1100_Fig3_HTML.gif
      isPartOf:
         name:Acta Neuropathologica
         issn:
            1432-0533
            0001-6322
         volumeNumber:125
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer-Verlag
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Christian Koelsche
            affiliation:
                  name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                  address:
                     name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Adelheid Wöhrer
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Astrid Jeibmann
            affiliation:
                  name:University Hospital MĂŒnster
                  address:
                     name:Institute of Neuropathology, University Hospital MĂŒnster, MĂŒnster, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Jens Schittenhelm
            affiliation:
                  name:University of TĂŒbingen
                  address:
                     name:Department of Neuropathology Institute of Pathology and Neuropathology, University of TĂŒbingen, TĂŒbingen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Genevieve Schindler
            affiliation:
                  name:Medical Faculty of the Ruhr University Bochum
                  address:
                     name:Department of Neurosurgery, Medical Faculty of the Ruhr University Bochum, Bochum, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Matthias Preusser
            affiliation:
                  name:Medical University of Vienna
                  address:
                     name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
                  name:Medical University of Vienna
                  address:
                     name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Felix Lasitschka
            affiliation:
                  name:University of Heidelberg
                  address:
                     name:Institute of Pathology, University of Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Andreas von Deimling
            affiliation:
                  name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                  address:
                     name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
            name:David Capper
            affiliation:
                  name:Ruprecht-Karls-UniversitĂ€t Heidelberg
                  address:
                     name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
                  name:German Cancer Research Center (DKFZ)
                  address:
                     name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Acta Neuropathologica
      issn:
         1432-0533
         0001-6322
      volumeNumber:125
Organization:
      name:Springer-Verlag
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Ruprecht-Karls-UniversitĂ€t Heidelberg
      address:
         name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:University Hospital MĂŒnster
      address:
         name:Institute of Neuropathology, University Hospital MĂŒnster, MĂŒnster, Germany
         type:PostalAddress
      name:University of TĂŒbingen
      address:
         name:Department of Neuropathology Institute of Pathology and Neuropathology, University of TĂŒbingen, TĂŒbingen, Germany
         type:PostalAddress
      name:Medical Faculty of the Ruhr University Bochum
      address:
         name:Department of Neurosurgery, Medical Faculty of the Ruhr University Bochum, Bochum, Germany
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:Medical University of Vienna
      address:
         name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
         type:PostalAddress
      name:University of Heidelberg
      address:
         name:Institute of Pathology, University of Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:Ruprecht-Karls-UniversitĂ€t Heidelberg
      address:
         name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
      name:Ruprecht-Karls-UniversitĂ€t Heidelberg
      address:
         name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
         type:PostalAddress
      name:German Cancer Research Center (DKFZ)
      address:
         name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Christian Koelsche
      affiliation:
            name:Ruprecht-Karls-UniversitĂ€t Heidelberg
            address:
               name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Adelheid Wöhrer
      affiliation:
            name:Medical University of Vienna
            address:
               name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Astrid Jeibmann
      affiliation:
            name:University Hospital MĂŒnster
            address:
               name:Institute of Neuropathology, University Hospital MĂŒnster, MĂŒnster, Germany
               type:PostalAddress
            type:Organization
      name:Jens Schittenhelm
      affiliation:
            name:University of TĂŒbingen
            address:
               name:Department of Neuropathology Institute of Pathology and Neuropathology, University of TĂŒbingen, TĂŒbingen, Germany
               type:PostalAddress
            type:Organization
      name:Genevieve Schindler
      affiliation:
            name:Medical Faculty of the Ruhr University Bochum
            address:
               name:Department of Neurosurgery, Medical Faculty of the Ruhr University Bochum, Bochum, Germany
               type:PostalAddress
            type:Organization
      name:Matthias Preusser
      affiliation:
            name:Medical University of Vienna
            address:
               name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
            name:Medical University of Vienna
            address:
               name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
               type:PostalAddress
            type:Organization
      name:Felix Lasitschka
      affiliation:
            name:University of Heidelberg
            address:
               name:Institute of Pathology, University of Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
      name:Andreas von Deimling
      affiliation:
            name:Ruprecht-Karls-UniversitĂ€t Heidelberg
            address:
               name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
      name:David Capper
      affiliation:
            name:Ruprecht-Karls-UniversitĂ€t Heidelberg
            address:
               name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
               type:PostalAddress
            type:Organization
            name:German Cancer Research Center (DKFZ)
            address:
               name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
               type:PostalAddress
            type:Organization
PostalAddress:
      name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Institute of Neurology, Medical University of Vienna, Vienna, Austria
      name:Institute of Neuropathology, University Hospital MĂŒnster, MĂŒnster, Germany
      name:Department of Neuropathology Institute of Pathology and Neuropathology, University of TĂŒbingen, TĂŒbingen, Germany
      name:Department of Neurosurgery, Medical Faculty of the Ruhr University Bochum, Bochum, Germany
      name:Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria
      name:Department of Medicine I, Medical University of Vienna, Vienna, Austria
      name:Institute of Pathology, University of Heidelberg, Heidelberg, Germany
      name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
      name:Department of Neuropathology, Ruprecht-Karls-UniversitĂ€t Heidelberg, Heidelberg, Germany
      name:Clinical Cooperation Unit Neuropathology, German Cancer Research Center (DKFZ), Heidelberg, Germany
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(208)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📩}

  • Crossref

4.62s.